Stockscreener 앱 받기
4.2212
4.28%
-0.1888
전일 마감가:
$4.41
열려 있는:
$4.4
하루 거래량:
170.66K
Relative Volume:
1.10
시가총액:
$238.27M
수익:
$34.16M
순이익/손실:
$-98.43M
주가수익비율:
-1.8039
EPS:
-2.34
순현금흐름:
$-119.33M
1주 성능:
+2.46%
1개월 성능:
-9.03%
6개월 성능:
-0.44%
1년 성능:
-49.14%
1일 변동 폭
$4.05
$4.49
1주일 범위
$4.03
$4.69
52주 변동 폭
$2.9448
$9.70
Foghorn Therapeutics Inc Stock (FHTX) Company Profile
명칭
Foghorn Therapeutics Inc
전화
617-586-3100
주소
500 TECHNOLOGY SQUARE, CAMBRIDGE
FHTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FHTX
Foghorn Therapeutics Inc
|
4.215 | 249.30M | 34.16M | -98.43M | -119.33M | -2.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.28 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
639.79 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.86 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.41 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.51 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Foghorn Therapeutics Inc Stock (FHTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 재개 | B. Riley Securities | Buy |
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-01-30 | 개시 | B. Riley Securities | Buy |
| 2024-09-03 | 개시 | Jefferies | Buy |
| 2024-08-19 | 개시 | Evercore ISI | Outperform |
| 2023-03-28 | 개시 | BofA Securities | Buy |
| 2023-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-11-22 | 개시 | H.C. Wainwright | Buy |
| 2020-11-17 | 개시 | Cowen | Outperform |
| 2020-11-17 | 개시 | Goldman | Buy |
| 2020-11-17 | 개시 | Morgan Stanley | Overweight |
| 2020-11-17 | 개시 | Wedbush | Outperform |
모두보기
Foghorn Therapeutics Inc 주식(FHTX)의 최신 뉴스
Identifying reversal signals in Foghorn Therapeutics Inc.2025 Market Overview & Fast Moving Stock Watchlists - newser.com
Is Foghorn Therapeutics Inc. stock safe for conservative investorsBull Run & Free Weekly Watchlist of Top Performers - newser.com
How Foghorn Therapeutics Inc. stock valuations compare to rivalsPrice Action & AI Driven Stock Movement Reports - newser.com
Foghorn Therapeutics to engage investors at oncology conferences - Traders Union
Foghorn Therapeutics Inc. to Participate in Major Healthcare Conferences in November 2025 - Quiver Quantitative
Foghorn Therapeutics (NASDAQ: FHTX) plans three investor events; webcasts for 90 days - Stock Titan
Is Foghorn Therapeutics Inc. stock bottoming outAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Applying big data sentiment scoring on Foghorn Therapeutics Inc.Short Setup & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-03 02:03:18 - newser.com
Why Foghorn Therapeutics Inc. stock could outperform in 2025Market Growth Report & Low Volatility Stock Recommendations - newser.com
Will Foghorn Therapeutics Inc. continue its uptrendWeekly Market Outlook & High Accuracy Buy Signal Tips - newser.com
How moving averages guide Foghorn Therapeutics Inc. tradingMarket Growth Report & Weekly Top Gainers Trade List - newser.com
Can swing trading help recover from Foghorn Therapeutics Inc. lossesJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Published on: 2025-11-02 02:35:38 - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.Market Performance Report & Verified Stock Trade Ideas - newser.com
Why Foghorn Therapeutics Inc. is moving todayPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 05:22:36 - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Watch List & Free Verified High Yield Trade Plans - newser.com
Foghorn Therapeutics shares progress on three protein degrader programs - BioWorld MedTech
Has Foghorn Therapeutics Inc. formed a bullish divergencePortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Foghorn Therapeutics advances ARID1B, CBP, EP300 development - Traders Union
Foghorn Therapeutics Announces Key Pipeline Updates - TipRanks
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs - The Manila Times
Foghorn Therapeutics Updates on Selective Degrader Programs and Virtual Investor Event Announcement - Quiver Quantitative
Foghorn Therapeutics Inc Announces Pipeline Updates for Degrader Programs - TradingView
Foghorn (Nasdaq: FHTX) updates degraders: ARID1B tied to 5% of solid tumors; CBP IND 2026 - Stock Titan
Momentum divergence signals in Foghorn Therapeutics Inc. chartQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - newser.com
How risky is Foghorn Therapeutics Inc. stock nowEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Volatility clustering patterns for Foghorn Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
Foghorn Therapeutics Inc (FHTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.05%
자본화:
|
볼륨(24시간):